Mycoses

Article	Citations
Author Index	60
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	52
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	51
	46
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	45
Physicians' knowledge of invasive fungal disease in China	45
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	44
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	41
Issue Information	39
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	35
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	35
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	34
Issue Information	34
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	33
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	33
Review Article White Piedra: Review of 131 cases	33
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	28
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	28
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	27
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	27
Emergence of Candida auris in intensive care units in Algeria	25
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	25
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	25
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	25
Issue Information	24

Issue Information	23
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	22
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	22
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	22
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	21
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	21
Cover Image	21
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	20
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	20
	19
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	19
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	19
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	19
Issue Information	19
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	18
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	18
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	18
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis	18
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review	18
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	17
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	17
	17
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	17
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	17
CARD9 mutations in patients with fungal infections: An update from the last 5 years	16
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	16
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	16
Tinea pedis in underrepresented groups: All of Us database analysis	16
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Tri	16
Diagnostic performance of noncultural methods for central nervous system aspergillosis	15
	15
	15
	15
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	15
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	15
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	15
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	15
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	15
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	14
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	14
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	14
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	14
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	13
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	13
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	13
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	13
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	13
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	13
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	12

Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	12
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	12
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	12
	12
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	12
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	12
	12
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	11
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	11
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	11
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	11
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	11
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	10
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	10
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	10
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	10
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
	10
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	10
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	10
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	10
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	9
Aspergillus nodules: Natural history and the effect of antifungals	9
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	9
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	9
Expert recommendations for prevention and management of Candida auris transmission	9
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	9
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	9
Issue Information	9
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	9
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Updated estimation of the burden of fungal disease in Vietnam	8
	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	8
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
Abstracts	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
Issue Information	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
Issue Information	6
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	6
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	6
Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	6
In Vitro Activity of Nitroxoline (5‐Nitro‐8‐Hydroxyquinoline) Against Aspergillus Species	6
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	6

Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytesITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen	6
	6
Invasive fungal infections in acute and chronic liver impairment: A systematic review	6
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	6
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	6
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	6
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	6
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	6
	6
Time and cost‐efficient identification of Trichophyton indotineae	6
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	6
The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism	6
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	6
	6
Issue Information	6
	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	6
Altered skin fungal and bacterial community compositions in tinea capitis	6
Deep Learning Models for CT Segmentation of Invasive Pulmonary Aspergillosis, Mucormycosis, Bacterial Pneumonia and Tuberculosis: A Multicentre Study	6
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran	6
Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population‐Based Cohort	6
Issue Information	6